ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Prima BioMed Ltd
1.71
0.0000
成交量：
- -
成交額：
- -
市值：
3,525.34萬
市盈率：
-0.81
高：
1.71
開：
1.71
低：
1.71
收：
1.71
52周最高：
3.26
52周最低：
1.40
股本：
2,061.60萬
流通股本：
1,928.15萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-2.1000
淨資產收益率：
--
總資產收益率：
--
市淨率：
1.43
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Prima BioMed Ltd
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.primabiomed.com.au
郵編：
- -
電話：
- -
傳真：
- -
簡介：
Prima BioMed Ltd是根據澳大利亞聯邦法律於1987年5月21日註冊成立的，Prima BioMed有限公司是一家澳大利亞的生物技術公司，致力於個性化生物治療產品，尤其專註於腫瘤學的發展。正在發展的關鍵候選產品是CVAC，這是基於自體樹突細胞的產品，用於晚期卵巢上皮癌患者在第一行手術和化療后，起到一個緩解的作用。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PBMD/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBMD\",,,,,undefined,":{"symbol":"PBMD","market":"US","secType":"STK","nameCN":"Prima BioMed Ltd","latestPrice":1.71,"timestamp":1512162000000,"preClose":1.71,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":19281474,"shares":20616000,"eps":-2.1,"marketStatus":"退市","change":0,"latestTime":"12-01 16:00:00 EST","open":1.71,"high":1.71,"low":1.71,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.1,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":0,"adr":1,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.71,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBMD\",,,,,undefined,":{"symbol":"PBMD","floatShares":19281474,"roa":"--","roe":"--","lyrEps":0,"shares":20616000,"dividePrice":0,"high":1.71,"amplitude":0,"preClose":1.71,"low":1.71,"week52Low":1.4,"pbRate":"1.43","week52High":3.26,"institutionHeld":0,"latestPrice":1.71,"eps":-2.1,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.1,"open":1.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-09-05","symbol":"PBMD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1473048000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBMD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.primabiomed.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Prima BioMed Ltd是根據澳大利亞聯邦法律於1987年5月21日註冊成立的，Prima BioMed有限公司是一家澳大利亞的生物技術公司，致力於個性化生物治療產品，尤其專註於腫瘤學的發展。正在發展的關鍵候選產品是CVAC，這是基於自體樹突細胞的產品，用於晚期卵巢上皮癌患者在第一行手術和化療后，起到一個緩解的作用。","exchange":"NASDAQ","name":"Prima BioMed Ltd","nameEN":"Prima Biomed"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PBMD\",market:\"US\",,,undefined,":null}}